Flow cytometric analysis of post-treatment blood samples from 3 of 4 AML patients (UPN01, UPN03, UPN06) showed decreased numbers of the circulating CD123+CD34+CD38- and CD33+CD34+CD38- cells (Table 2). Here, CD38 is linked to acute myeloid leukemia.